{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:03:44Z","timestamp":1790251424919,"version":"4.1.0"},"reference-count":132,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100010803","name":"Department of Biotechnology","doi-asserted-by":"crossref","award":["BTP\/Budget\/RD-38\/2017"],"award-info":[{"award-number":["BTP\/Budget\/RD-38\/2017"]}],"id":[{"id":"10.13039\/501100010803","id-type":"DOI","asserted-by":"crossref"}]},{"name":"DST-FIST"},{"name":"UGC-SAP","award":["F5-3\/2018\/DRS-II"],"award-info":[{"award-number":["F5-3\/2018\/DRS-II"]}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["Fellowship\/21\/2018-ECD-II"],"award-info":[{"award-number":["Fellowship\/21\/2018-ECD-II"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004597","name":"University of Kalyani","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004597","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.jgar.2019.01.023","type":"journal-article","created":{"date-parts":[[2019,1,27]],"date-time":"2019-01-27T06:29:19Z","timestamp":1548570559000},"page":"1-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"special_numbering":"C","title":["Drug Resistance in Protozoan Parasites: An Incessant Wrestle for Survival"],"prefix":"10.1016","volume":"18","author":[{"given":"Pijush Kanti","family":"Pramanik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Nur","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dibyapriya","family":"Roy Chowdhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tapati","family":"Chakraborti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2019.01.023_bib0005","doi-asserted-by":"crossref","first-page":"541340","DOI":"10.1155\/2014\/541340","article-title":"Multidrug resistance: an emerging crisis","volume":"2014","author":"Tanwar","year":"2014","journal-title":"Interdiscip Perspect Infect Dis"},{"key":"10.1016\/j.jgar.2019.01.023_bib0010","doi-asserted-by":"crossref","first-page":"16092","DOI":"10.1038\/nmicrobiol.2016.92","article-title":"Drug resistance in eukaryotic microorganisms","volume":"1","author":"Fairlamb","year":"2016","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.jgar.2019.01.023_bib0015","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0924-8579(03)00210-3","article-title":"ABC transporters and drug resistance in parasitic protozoa","volume":"22","author":"Klokouzas","year":"2003","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jgar.2019.01.023_bib0020","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/1574-6976.12032","article-title":"Drug resistance in vectorborne parasites: multiple actors and scenarios for an evolutionary arms race","volume":"38","author":"Vanaerschot","year":"2014","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.jgar.2019.01.023_bib0025","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1146\/annurev.mi.49.100195.002235","article-title":"New mechanisms of drug resistance in parasitic protozoa","volume":"49","author":"Borst","year":"1995","journal-title":"Annu Rev Microbiol"},{"key":"10.1016\/j.jgar.2019.01.023_bib0030","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.molbiopara.2017.07.001","article-title":"ABC transporters in the liver fluke Opisthorchis felineus","volume":"216","author":"Mordvinov","year":"2017","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.jgar.2019.01.023_bib0035","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/hdy.2014.84","article-title":"The evolutionary ecology of complex lifecycle parasites: linking phenomena with mechanisms","volume":"114","author":"Auld","year":"2015","journal-title":"Heredity (Edinb)"},{"key":"10.1016\/j.jgar.2019.01.023_bib0040","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1042\/ETLS20170113","article-title":"Drug resistance in protozoan parasites","volume":"1","author":"De Koning","year":"2017","journal-title":"Emerg Top Life Sci"},{"key":"10.1016\/j.jgar.2019.01.023_bib0045","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.2217\/fmb.10.136","article-title":"Antimalarial drugs: modes of action and mechanisms of parasite resistance","volume":"5","author":"M\u00fcller","year":"2010","journal-title":"Future Microbiol"},{"key":"10.1016\/j.jgar.2019.01.023_bib0050","first-page":"49","article-title":"Ronald Ross and the malaria\u2013mosquito cycle","volume":"41","author":"Bynum","year":"1999","journal-title":"Parassitologia"},{"key":"10.1016\/j.jgar.2019.01.023_bib0055","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/1475-2875-10-144","article-title":"Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria","volume":"10","author":"Achan","year":"2011","journal-title":"Malar J"},{"key":"10.1016\/j.jgar.2019.01.023_bib0060","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ijantimicag.2012.12.007","article-title":"Antimalarial drug resistance: a review of the biology and strategies to delay emergence and spread","volume":"41","author":"Klein","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jgar.2019.01.023_bib0065","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/j.febslet.2011.04.042","article-title":"Drug-resistant malaria: molecular mechanisms and implications for public health","volume":"585","author":"Petersen","year":"2011","journal-title":"FEBS Lett"},{"issue":"Suppl. 3","key":"10.1016\/j.jgar.2019.01.023_bib0070","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1016\/j.ijid.2009.11.035","article-title":"High prevalence of the 437G mutation associated with sulfadoxine resistance among Plasmodium falciparum clinical isolates from Iran, three years after the introduction of sulfadoxine\u2013pyrimethamine","volume":"14","author":"Zakeri","year":"2010","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jgar.2019.01.023_bib0075","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ijpara.2010.08.008","article-title":"Whole genome re-sequencing identifies a mutation in an ABC transporter (mdr2) in a Plasmodium chabaudi clone with altered susceptibility to antifolate drugs","volume":"41","author":"Martinelli","year":"2011","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.jgar.2019.01.023_bib0080","doi-asserted-by":"crossref","first-page":"11553","DOI":"10.1038\/ncomms11553","article-title":"Globally prevalent PfMDR1 mutations modulate Plasmodium falciparum susceptibility to artemisinin-based combination therapies","volume":"7","author":"Veiga","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.jgar.2019.01.023_bib0085","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.exppara.2008.02.011","article-title":"Plasmodium chabaudi: efficacy of artemisinin+curcumin combination treatment on a clone selected for artemisinin resistance in mice","volume":"119","author":"Martinelli","year":"2008","journal-title":"Exp Parasitol"},{"key":"10.1016\/j.jgar.2019.01.023_bib0090","article-title":"Artemisinin directly targets malarial mitochondria through its specific mitochondrial activation","volume":"5","author":"Wang","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jgar.2019.01.023_bib0095","doi-asserted-by":"crossref","first-page":"30106","DOI":"10.1038\/srep30106","article-title":"Mechanism of artemisinin resistance for malaria PfATP6 L263 mutations and discovering potential antimalarials: an integrated computational approach","volume":"6","author":"Nagasundaram","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jgar.2019.01.023_bib0100","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a025619","article-title":"Antimalarial drug resistance: a threat to malaria elimination","volume":"7","author":"Menard","year":"2017","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.jgar.2019.01.023_bib0105","doi-asserted-by":"crossref","first-page":"16690","DOI":"10.1038\/s41598-017-16866-5","article-title":"Prevalence of mutations linked to antimalarial resistance in Plasmodium falciparum from Chhattisgarh, Central India: a malaria elimination point of view","volume":"7","author":"Patel","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jgar.2019.01.023_bib0110","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4269\/ajtmh.2012.12-0359","article-title":"Plasmodium falciparum Na+\/H+ exchanger (pfnhe-1) genetic polymorphism in Indian Ocean malaria-endemic areas","volume":"88","author":"Andriantsoanirina","year":"2013","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.jgar.2019.01.023_bib0115","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1046\/j.1472-8206.2003.00164.x","article-title":"The mechanisms of resistance to antimalarial drugs in Plasmodium falciparum","volume":"17","author":"Le Bras","year":"2003","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.jgar.2019.01.023_bib0120","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.molbiopara.2005.07.009","article-title":"PfCG2, a Plasmodium falciparum protein peripherally associated with the parasitophorous vacuolar membrane, is expressed in the period of maximum hemoglobin uptake and digestion by trophozoites","volume":"144","author":"Cooper","year":"2005","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.jgar.2019.01.023_bib0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0014064","article-title":"On the mechanism of chloroquine resistance in Plasmodium falciparum","volume":"5","author":"Chinappi","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jgar.2019.01.023_bib0130","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1128\/AAC.05618-11","article-title":"The F423Y mutation in the pfmdr2 gene and mutations N51I, C59R, and S108N in the pfdhfr gene are independently associated with pyrimethamine resistance in Plasmodium falciparum isolates","volume":"56","author":"Briolant","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2019.01.023_bib0135","doi-asserted-by":"crossref","first-page":"ofu059","DOI":"10.1093\/ofid\/ofu059","article-title":"Novel mutation in cytochrome B of Plasmodium falciparum in one of two atovaquone\u2013proguanil treatment failures in travelers returning from same site in Nigeria","volume":"1","author":"Plucinski","year":"2014","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jgar.2019.01.023_bib0140","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1016\/j.bmcl.2013.03.067","article-title":"Recent advances in malaria drug discovery","volume":"23","author":"Biamonte","year":"2013","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.jgar.2019.01.023_bib0145","doi-asserted-by":"crossref","first-page":"177ra37","DOI":"10.1126\/scitranslmed.3005029","article-title":"Quinolone-3-diarylethers: a new class of antimalarial drug","volume":"5","author":"Nilsen","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jgar.2019.01.023_bib0150","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.biopha.2016.08.046","article-title":"Protective inflammatory response against visceral leishmaniasis with potato tuber extract: a new approach of successful therapy","volume":"83","author":"Paik","year":"2016","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jgar.2019.01.023_bib0155","first-page":"125","article-title":"A new form of cutaneous leishmaniasis\u2014dermal leishmanoid","volume":"57","author":"Brahmachari","year":"1922","journal-title":"Ind Med Gaz"},{"key":"10.1016\/j.jgar.2019.01.023_bib0160","doi-asserted-by":"crossref","first-page":"571242","DOI":"10.4061\/2011\/571242","article-title":"Use of antimony in the treatment of leishmaniasis: current status and future directions","volume":"2011","author":"Haldar","year":"2011","journal-title":"Mol Biol Int"},{"key":"10.1016\/j.jgar.2019.01.023_bib0165","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1086\/314896","article-title":"Evidence that the high incidence of treatment failures in Indian kala-azar is due to the emergence of antimony-resistant strains of Leishmania donovani","volume":"180","author":"Lira","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jgar.2019.01.023_bib0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003021","article-title":"Visceral leishmaniasis and HIV coinfection in the Mediterranean region","volume":"8","author":"Monge-Maillo","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.jgar.2019.01.023_bib0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004304","article-title":"Antimony to cure visceral leishmaniasis unresponsive to liposomal amphotericin B","volume":"10","author":"Morizot","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.jgar.2019.01.023_bib0180","doi-asserted-by":"crossref","first-page":"646932","DOI":"10.1155\/2014\/646932","article-title":"Strategies to overcome antileishmanial drugs unresponsiveness","volume":"2014","author":"Sundar","year":"2014","journal-title":"J Trop Med"},{"key":"10.1016\/j.jgar.2019.01.023_bib0185","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1128\/AAC.00030-11","article-title":"Mechanism of amphotericin B resistance in clinical isolates of Leishmania donovani","volume":"56","author":"Purkait","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2019.01.023_bib0190","doi-asserted-by":"crossref","first-page":"4141","DOI":"10.1038\/s41598-017-03943-y","article-title":"Mahanine exerts in vitro and in vivo antileishmanial activity by modulation of redox homeostasis","volume":"7","author":"Roy","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jgar.2019.01.023_bib0195","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4103\/2229-5070.129142","article-title":"Drug resistance in leishmaniasis: newer developments","volume":"4","author":"Mohapatra","year":"2014","journal-title":"Trop Parasitol"},{"key":"10.1016\/j.jgar.2019.01.023_bib0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005649","article-title":"Sterol 14\u03b1-demethylase mutation leads to amphotericin B resistance in Leishmania mexicana","volume":"11","author":"Mwenechanya","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.jgar.2019.01.023_bib0205","doi-asserted-by":"crossref","first-page":"E3012","DOI":"10.1073\/pnas.1520693113","article-title":"Cos-Seq for high-throughput identification of drug target and resistance mechanisms in the protozoan parasite Leishmania","volume":"113","author":"Gazanion","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jgar.2019.01.023_bib0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006052","article-title":"Drug resistance and treatment failure in leishmaniasis: a 21st century challenge","volume":"11","author":"Ponte-Sucre","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.jgar.2019.01.023_bib0215","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0020-7519(01)00346-0","article-title":"Pterin transport and metabolism in Leishmania and related trypanosomatid parasites","volume":"32","author":"Ouellette","year":"2002","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.jgar.2019.01.023_bib0220","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1042\/bse0510063","article-title":"Folate metabolic pathways in Leishmania","volume":"51","author":"Vickers","year":"2011","journal-title":"Essays Biochem"},{"key":"10.1016\/j.jgar.2019.01.023_bib0225","doi-asserted-by":"crossref","first-page":"5886","DOI":"10.1093\/nar\/gkg806","article-title":"Modulation of gene expression in Leishmania drug resistant mutants as determined by targeted DNA microarrays","volume":"31","author":"Guimond","year":"2003","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jgar.2019.01.023_bib0230","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.pt.2012.12.005","article-title":"Drug resistance in African trypanosomiasis: the melarsoprol and pentamidine story","volume":"29","author":"Baker","year":"2013","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.jgar.2019.01.023_bib0235","first-page":"876","article-title":"Diamidines for human African trypanosomiasis","volume":"11","author":"Paine","year":"2010","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1016\/j.jgar.2019.01.023_bib0240","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1756-3305-3-15","article-title":"The development of drugs for treatment of sleeping sickness: a historical review","volume":"3","author":"Steverding","year":"2010","journal-title":"Parasit Vectors"},{"key":"10.1016\/j.jgar.2019.01.023_bib0245","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nrmicro.2016.193","article-title":"Anti-trypanosomatid drug discovery: an ongoing challenge and a continuing need","volume":"15","author":"Field","year":"2017","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.jgar.2019.01.023_bib0250","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.jacc.2016.12.023","article-title":"Benznidazole and posaconazole in eliminating parasites in asymptomatic T. cruzi carriers: the STOP-CHAGAS Trial","volume":"69","author":"Morillo","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jgar.2019.01.023_bib0255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0092028","article-title":"Proline modulates the Trypanosoma cruzi resistance to reactive oxygen species and drugs through a novel d, l-proline transporter","volume":"9","author":"Say\u00e9","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jgar.2019.01.023_bib0260","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3389\/fphar.2015.00032","article-title":"Transport proteins determine drug sensitivity and resistance in a protozoan parasite, Trypanosoma brucei","volume":"6","author":"Munday","year":"2015","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jgar.2019.01.023_bib0265","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1124\/mol.106.024653","article-title":"Roles for the Trypanosoma brucei P2 transporter in DB75 uptake and resistance","volume":"70","author":"Lanteri","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jgar.2019.01.023_bib0270","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1128\/EC.00287-10","article-title":"Nutrient transport and pathogenesis in selected parasitic protozoa","volume":"10","author":"Landfear","year":"2011","journal-title":"Eukaryot Cell"},{"key":"10.1016\/j.jgar.2019.01.023_bib0275","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/jac\/dkt442","article-title":"Trypanosoma brucei aquaglyceroporin 2 is a high-affinity transporter for pentamidine and melaminophenyl arsenic drugs and the main genetic determinant of resistance to these drugs","volume":"69","author":"Munday","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2019.01.023_bib0280","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.pt.2018.04.002","article-title":"Melarsoprol resistance in African trypanosomiasis","volume":"34","author":"Fairlamb","year":"2018","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.jgar.2019.01.023_bib0285","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ijpddr.2015.04.002","article-title":"Chimerization at the AQP2\u2013AQP3 locus is the genetic basis of melarsoprol\u2013pentamidine cross-resistance in clinical Trypanosoma brucei gambiense isolates","volume":"5","author":"Graf","year":"2015","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"10.1016\/j.jgar.2019.01.023_bib0290","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004942","article-title":"Specific cell targeting therapy bypasses drug resistance mechanisms in African trypanosomiasis","volume":"11","author":"Unciti-Broceta","year":"2015","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jgar.2019.01.023_bib0295","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nature10771","article-title":"High-throughput decoding of antitrypanosomal drug efficacy and resistance","volume":"482","author":"Alsford","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jgar.2019.01.023_bib0300","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/jac\/dkv376","article-title":"Nitroheterocyclic drug resistance mechanisms in Trypanosoma brucei","volume":"71","author":"Wyllie","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2019.01.023_bib0305","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/infdis\/jis331","article-title":"Benznidazole-resistance in Trypanosoma cruzi is a readily acquired trait that can arise independently in a single population","volume":"206","author":"Mejia","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jgar.2019.01.023_bib0310","doi-asserted-by":"crossref","first-page":"14407","DOI":"10.1038\/s41598-017-14986-6","article-title":"Genome-wide mutagenesis and multi-drug resistance in American trypanosomes induced by the front-line drug benznidazole","volume":"7","author":"Campos","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jgar.2019.01.023_bib0315","series-title":"Amebiasis: biology and pathogenesis of Entamoeba","year":"2015"},{"key":"10.1016\/j.jgar.2019.01.023_bib0320","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S0021-9258(17)32778-3","article-title":"An energy-conserving pyruvate-to-acetate pathway in Entamoeba histolytica. Pyruvate synthase and a new acetate thiokinase","volume":"252","author":"Reeves","year":"1977","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jgar.2019.01.023_bib0325","doi-asserted-by":"crossref","first-page":"7285","DOI":"10.1074\/jbc.273.13.7285","article-title":"Transcriptional analysis of the EhPgp5 promoter of Entamoeba histolytica multidrug-resistant mutant","volume":"273","author":"P\u00e9rez","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jgar.2019.01.023_bib0330","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S1383-5769(02)00041-7","article-title":"Multidrug resistance in the protozoan parasite Entamoeba histolytica","volume":"51","author":"Orozco","year":"2002","journal-title":"Parasitol Int"},{"key":"10.1016\/j.jgar.2019.01.023_bib0335","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001161","article-title":"Genetic reconstruction of protozoan rRNA decoding sites provides a rationale for paromomycin activity against Leishmania and Trypanosoma","volume":"5","author":"Hobbie","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.jgar.2019.01.023_bib0340","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ijpddr.2014.02.002","article-title":"Drug repurposing and human parasitic protozoan diseases","volume":"4","author":"Andrews","year":"2014","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"10.1016\/j.jgar.2019.01.023_bib0345","doi-asserted-by":"crossref","first-page":"26051","DOI":"10.1074\/jbc.274.37.26051","article-title":"Metronidazole resistance in the protozoan parasite Entamoeba histolytica is associated with increased expression of iron-containing superoxide dismutase and peroxiredoxin and decreased expression of ferredoxin 1 and flavin reductase","volume":"274","author":"Wassmann","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jgar.2019.01.023_bib0350","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ijantimicag.2009.08.016","article-title":"Cytotoxic effect of amide derivatives of trifluoromethionine against the enteric protozoan parasite Entamoeba histolytica","volume":"35","author":"Sato","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jgar.2019.01.023_bib0355","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1093\/jac\/dkr238","article-title":"Mechanism of trifluoromethionine resistance in Entamoeba histolytica","volume":"66","author":"Penuliar","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2019.01.023_bib0360","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/jac\/dkr484","article-title":"Transcriptional and functional analysis of trifluoromethionine resistance in Entamoeba histolytica","volume":"67","author":"Penuliar","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2019.01.023_bib0365","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.molbiopara.2015.11.004","article-title":"Kaempferol inhibits Entamoeba histolytica growth by altering cytoskeletal functions","volume":"204","author":"Bola\u00f1os","year":"2015","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.jgar.2019.01.023_bib0370","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1186\/1471-2164-14-467","article-title":"Genetic basis for phenotypic differences between different Toxoplasma gondii type I strains","volume":"14","author":"Yang","year":"2013","journal-title":"BMC Genomics"},{"key":"10.1016\/j.jgar.2019.01.023_bib0375","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1128\/CMR.05013-11","article-title":"Epidemiology of and diagnostic strategies for toxoplasmosis","volume":"25","author":"Robert-Gangneux","year":"2012","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jgar.2019.01.023_bib0380","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1086\/340577","article-title":"The molecular basis of sulfonamide resistance in Toxoplasma gondii and implications for the clinical management of toxoplasmosis","volume":"185","author":"Aspinall","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jgar.2019.01.023_bib0385","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.ijpara.2009.02.004","article-title":"Toxoplasmosis a history of clinical observations","volume":"39","author":"Weiss","year":"2009","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.jgar.2019.01.023_bib0390","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1128\/AAC.01203-07","article-title":"In vitro susceptibility of various genotypic strains of Toxoplasma gondii to pyrimethamine, sulfadiazine, and atovaquone","volume":"52","author":"Meneceur","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2019.01.023_bib0395","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0166-6851(00)00184-5","article-title":"Characterization of cytochrome b from Toxoplasma gondii and Q(o) domain mutations as a mechanism of atovaquone-resistance","volume":"108","author":"McFadden","year":"2000","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.jgar.2019.01.023_bib0400","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1051\/parasite\/2013020","article-title":"Sulfadiazine resistance in Toxoplasma gondii: no involvement of overexpression or polymorphisms in genes of therapeutic targets and ABC transporters","volume":"20","author":"Doliwa","year":"2013","journal-title":"Parasite"},{"key":"10.1016\/j.jgar.2019.01.023_bib0405","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.molbiopara.2009.05.005","article-title":"The role of ATP-binding cassette (ABC) proteins in protozoan parasites","volume":"167","author":"Sauvage","year":"2009","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.jgar.2019.01.023_bib0410","article-title":"Genetic polymorphisms and phenotypic profiles of sulfadiazine-resistant and sensitive Toxoplasma gondii isolates obtained from newborns with congenital toxoplasmosis in Minas Gerais Brazil","volume":"12","author":"Silva","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jgar.2019.01.023_bib0415","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.4161\/hv.21006","article-title":"Vaccines against Toxoplasma gondii: status, challenges and future directions","volume":"8","author":"Liu","year":"2012","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.jgar.2019.01.023_bib0420","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2147\/VDT.S57474","article-title":"Current progress toward vaccines against Toxoplasma gondii","volume":"4","author":"Garcia","year":"2014","journal-title":"Vaccine Devel Ther"},{"key":"10.1016\/j.jgar.2019.01.023_bib0425","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1101\/gr.184901","article-title":"The human ATP-binding cassette (ABC) transporter superfamily","volume":"11","author":"Dean","year":"2001","journal-title":"Genome Res"},{"key":"10.1016\/j.jgar.2019.01.023_bib0430","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4103\/2229-5070.175081","article-title":"Antimalarial drug resistance: an overview","volume":"6","author":"Antony","year":"2016","journal-title":"Trop Parasitol"},{"key":"10.1016\/j.jgar.2019.01.023_bib0435","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1111\/jcmm.12313","article-title":"Assessment of Plasmodium falciparum PfMDR1 transport rates using Fluo-4","volume":"18","author":"Friedrich","year":"2014","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.jgar.2019.01.023_bib0440","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.actatropica.2005.04.008","article-title":"Contribution of the pfmdr1 gene to antimalarial drug-resistance","volume":"94","author":"Duraisingh","year":"2005","journal-title":"Acta Trop"},{"key":"10.1016\/j.jgar.2019.01.023_bib0445","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/0092-8674(89)90330-9","article-title":"Amplification of the multidrug resistance gene in some chloroquine-resistant isolates of P. falciparum","volume":"57","author":"Foote","year":"1989","journal-title":"Cell"},{"key":"10.1016\/j.jgar.2019.01.023_bib0450","doi-asserted-by":"crossref","first-page":"7032","DOI":"10.1128\/AAC.03494-14","article-title":"Role of Pfmdr1 in in vitro Plasmodium falciparum susceptibility to chloroquine, quinine, monodesethylamodiaquine, mefloquine, lumefantrine, and dihydroartemisinin","volume":"58","author":"Wurtz","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2019.01.023_bib0455","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.pt.2010.05.002","article-title":"The ABCs of multidrug resistance in malaria","volume":"26","author":"Koenderink","year":"2010","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.jgar.2019.01.023_bib0460","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/1475-2875-8-89","article-title":"A systematic review and meta-analysis of evidence for correlation between molecular markers of parasite resistance and treatment outcome in falciparum malaria","volume":"8","author":"Picot","year":"2009","journal-title":"Malar J"},{"key":"10.1016\/j.jgar.2019.01.023_bib0465","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1111\/j.1365-2958.2010.07531.x","article-title":"A new ATP-binding cassette protein is involved in intracellular haem trafficking in Leishmania","volume":"79","author":"Campos-Salinas","year":"2011","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.jgar.2019.01.023_bib0470","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1128\/AAC.00211-13","article-title":"A new ABC half-transporter in Leishmania major is involved in resistance to antimony","volume":"57","author":"Manzano","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2019.01.023_bib0475","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.bbrc.2005.02.176","article-title":"The overexpression of an intracellular ABCA-like transporter alters phospholipid trafficking in Leishmania","volume":"330","author":"Ara\u00fajo-Santos","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jgar.2019.01.023_bib0480","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1099\/jmm.0.46841-0","article-title":"Molecular mechanisms of antimony resistance in Leishmania","volume":"56","author":"Ashutosh Sundar","year":"2007","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.jgar.2019.01.023_bib0485","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1128\/AAC.01474-08","article-title":"Intracellular localization of the ABCC proteins of Leishmania and their role in resistance to antimonials","volume":"53","author":"Leprohon","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2019.01.023_bib0490","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1128\/CMR.19.1.111-126.2006","article-title":"Drug resistance in leishmaniasis","volume":"19","author":"Croft","year":"2006","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jgar.2019.01.023_bib0495","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0065467","article-title":"Drug resistance in natural isolates of Leishmania donovani s.l. promastigotes is dependent of Pgp170 expression","volume":"8","author":"Messaritakis","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jgar.2019.01.023_bib0500","volume":"vol. 2","author":"Mayers","year":"2017"},{"key":"10.1016\/j.jgar.2019.01.023_bib0505","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1128\/AAC.46.12.3731-3738.2002","article-title":"Resistance to pentamidine in Leishmania mexicana involves exclusion of the drug from the mitochondrion","volume":"46","author":"Basselin","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2019.01.023_bib0510","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1128\/EC.00152-06","article-title":"Modulation of Leishmania ABC protein gene expression through life stages and among drug-resistant parasites","volume":"5","author":"Leprohon","year":"2006","journal-title":"Eukaryot Cell"},{"key":"10.1016\/j.jgar.2019.01.023_bib0515","doi-asserted-by":"crossref","first-page":"3527","DOI":"10.3390\/ijms13033527","article-title":"Arsenic and antimony transporters in eukaryotes","volume":"13","author":"Maciaszczyk-Dziubinska","year":"2012","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jgar.2019.01.023_bib0520","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0166-6851(03)00162-2","article-title":"Functional genetic identification of PRP1, an ABC transporter superfamily member conferring pentamidine resistance in Leishmania major","volume":"130","author":"Coelho","year":"2003","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.jgar.2019.01.023_bib0525","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1128\/AAC.00404-07","article-title":"Role of the ABC transporter PRP1 (ABCC7) in pentamidine resistance in Leishmania amastigotes","volume":"51","author":"Coelho","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2019.01.023_bib0530","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1111\/j.1365-2958.2003.03927.x","article-title":"Localization and activity of multidrug resistance protein 1 in the secretory pathway of Leishmania parasites","volume":"51","author":"Dodge","year":"2004","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.jgar.2019.01.023_bib0535","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1128\/AAC.00998-06","article-title":"Flavonoid dimers as bivalent modulators for pentamidine and sodium stiboglucanate resistance in Leishmania","volume":"51","author":"Wong","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2019.01.023_bib0540","series-title":"Comprehensive analysis of parasite biology: from metabolism to drug discovery","author":"M\u00fcller","year":"2017"},{"key":"10.1016\/j.jgar.2019.01.023_bib0545","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001512","article-title":"Multiple mutations in heterogeneous miltefosine-resistant Leishmania major population as determined by whole genome sequencing","volume":"6","author":"Coelho","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.jgar.2019.01.023_bib0550","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1128\/AAC.00065-11","article-title":"Sitamaquine overcomes ABC-mediated resistance to miltefosine and antimony in Leishmania","volume":"55","author":"P\u00e9rez-Victoria","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2019.01.023_bib0555","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.molbiopara.2007.12.007","article-title":"A novel ATP-binding cassette transporter ABCG6 is involved in chemoresistance of Leishmania","volume":"158","author":"BoseDasgupta","year":"2008","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.jgar.2019.01.023_bib0560","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1128\/AAC.01648-08","article-title":"Topoisomerase I gene mutations at F270 in the large subunit and N184 in the small subunit contribute to the resistance mechanism of the unicellular parasite Leishmania donovani towards 3, 3'-diindolylmethane","volume":"53","author":"Roy","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2019.01.023_bib0565","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1128\/AAC.01574-13","article-title":"Elucidation of cellular mechanisms involved in experimental paromomycin resistance in Leishmania donovani","volume":"58","author":"Bhandari","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2019.01.023_bib0570","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1016\/0006-2952(94)90067-1","article-title":"P-glycoprotein overexpression in methotrexate-resistant Leishmania tropica","volume":"47","author":"Gamarro","year":"1994","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jgar.2019.01.023_bib0575","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.molbiopara.2006.07.010","article-title":"Combined contribution of TbAT1 and TbMRPA to drug resistance in Trypanosoma brucei","volume":"150","author":"L\u00fcscher","year":"2006","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.jgar.2019.01.023_bib0580","series-title":"ABC transporters and multidrug resistance","year":"2009"},{"key":"10.1016\/j.jgar.2019.01.023_bib0585","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.molbiopara.2005.10.016","article-title":"The role of Trypanosoma brucei MRPA in melarsoprol susceptibility","volume":"146","author":"Alibu","year":"2006","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.jgar.2019.01.023_bib0590","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0166-6851(92)90023-D","article-title":"Characterisation of melarsen-resistant Trypanosoma brucei brucei with respect to cross-resistance to other drugs and trypanothione metabolism","volume":"53","author":"Fairlamb","year":"1992","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.jgar.2019.01.023_bib0595","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1017\/S003118201300022X","article-title":"Genetic dissection of drug resistance in trypanosomes","volume":"140","author":"Alsford","year":"2013","journal-title":"Parasitology"},{"key":"10.1016\/j.jgar.2019.01.023_bib0600","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0006-2952(76)90213-6","article-title":"Pentamidine transport in Trypanosoma brucei\u2014kinetics and specificity","volume":"25","author":"Damper","year":"1976","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jgar.2019.01.023_bib0605","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/mmi.12979","article-title":"Functional analysis of drug resistance-associated mutations in the Trypanosoma brucei adenosine transporter 1 (TbAT1) and the proposal of a structural model for the protein","volume":"96","author":"Munday","year":"2015","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.jgar.2019.01.023_bib0610","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1046\/j.1365-2958.2002.02831.x","article-title":"Overexpression of the putative thiol conjugate transporter TbMRPA causes melarsoprol resistance in Trypanosoma brucei","volume":"43","author":"Shahi","year":"2002","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.jgar.2019.01.023_bib0615","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.molbiopara.2014.01.002","article-title":"Benznidazole-resistance in Trypanosoma cruzi: evidence that distinct mechanisms can act in concert","volume":"193","author":"Campos","year":"2014","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.jgar.2019.01.023_bib0620","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1590\/0074-02760140407","article-title":"A novel ABCG-like transporter of Trypanosoma cruzi is involved in natural resistance to benznidazole","volume":"110","author":"Zingales","year":"2015","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.jgar.2019.01.023_bib0625","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.meegid.2015.01.030","article-title":"ABCG-like transporter of Trypanosoma cruzi involved in benznidazole resistance: gene polymorphisms disclose inter-strain intragenic recombination in hybrid isolates","volume":"31","author":"Franco","year":"2015","journal-title":"Infect Genet Evol"},{"key":"10.1016\/j.jgar.2019.01.023_bib0630","first-page":"189","article-title":"Multidrug resistance in amoebiasis patients","volume":"124","author":"Bansal","year":"2006","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.jgar.2019.01.023_bib0635","doi-asserted-by":"crossref","first-page":"492","DOI":"10.3389\/fcimb.2017.00492","article-title":"A novel heat shock element (HSE) in Entamoeba histolytica that regulates the transcriptional activation of the EhPgp5 gene in the presence of emetine drug","volume":"7","author":"Nieto","year":"2017","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.jgar.2019.01.023_bib0640","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1128\/AAC.43.7.1533","article-title":"Why metronidazole is active against both bacteria and parasites","volume":"43","author":"Samuelson","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2019.01.023_bib0645","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1128\/AAC.36.11.2392","article-title":"Susceptibility of an emetine-resistant mutant of Entamoeba histolytica to multiple drugs and to channel blockers","volume":"36","author":"Samuelson","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2019.01.023_bib0650","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.molbiopara.2006.02.008","article-title":"Identification and expression analysis of ABC protein-encoding genes in Toxoplasma gondii. Toxoplasma gondii ATP-binding cassette superfamily","volume":"147","author":"Sauvage","year":"2006","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.jgar.2019.01.023_bib0655","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.molbiopara.2003.08.015","article-title":"P-glycoprotein inhibitors modulate accumulation and efflux of xenobiotics in extra and intracellular Toxoplasma gondii","volume":"134","author":"Sauvage","year":"2004","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.jgar.2019.01.023_bib0660","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1146\/annurev.pharmtox.39.1.361","article-title":"Biochemical, cellular, and pharmacological aspects of the multidrug transporter","volume":"39","author":"Ambudkar","year":"1999","journal-title":"Annu Rev Pharmacol Toxicol"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221371651930030X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221371651930030X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T09:56:30Z","timestamp":1761990990000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221371651930030X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":132,"alternative-id":["S221371651930030X"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2019.01.023","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug Resistance in Protozoan Parasites: An Incessant Wrestle for Survival","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2019.01.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 International Society for Chemotherapy of Infection and Cancer. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}